Saw Palmetto vs Finasteride: Which Is Better for Prostate?
Every year, millions of men wrestle with this question, and the honest answer is: it depends. Finasteride is an FDA-approved prescription drug backed by decades of clinical trial data; saw palmetto (Serenoa repens) is a dietary supplement drawn from a palm plant native to the southeastern US, with more modest and less consistent evidence behind it. The right call comes down to how severe your symptoms are, how much risk you’ll tolerate, and what your doctor recommends for your particular case.
Enlarged prostate (BPH) is behind most urinary complaints men over 50 deal with, weak flow, frequent urges, and repeated nighttime bathroom trips. Before weighing any treatment, it’s worth learning how BPH develops through BPH signs and causes, and understanding how it connects to lower urinary tract symptoms adds important context. A 2025 review of finasteride for BPH confirms it’s still a first-line pharmacological option for men with moderate-to-severe symptoms and larger prostate volume (preprints.org, 2025).
What These Two Do Differently
Both finasteride and saw palmetto target the same hormone pathway, but they get there by different routes and with different levels of potency.How finasteride works
Finasteride works by blocking 5-alpha reductase, the enzyme responsible for converting testosterone into dihydrotestosterone (DHT). DHT is the primary driver of prostate tissue growth, and understanding DHT makes clear why cutting its levels can shrink an enlarged prostate and ease the pressure it puts on the urethra. It’s that roughly 70% reduction in circulating DHT that makes finasteride’s effects on prostate size measurable and durable across years of use.How saw palmetto works
Saw palmetto is thought to work through a similar but weaker pathway, mainly by modulating DHT at the receptor level rather than sharply cutting overall DHT concentrations. Its estimated DHT reduction sits around 20 to 30%, and the evidence for that mechanism in humans is less firmly established. A 2024 multicenter RCT found the two produced comparable IPSS symptom improvements at six months, though finasteride’s disease-modifying effects at the tissue level are far better documented. Review saw palmetto’s dosage, benefits, and known side effects before starting it.How Each Treatment Is Measured and Monitored
Clinicians assess BPH treatment using three main tools: the International Prostate Symptom Score (IPSS), a validated questionnaire rating urinary symptoms from 0 to 35; uroflowmetry, which measures peak urinary flow rate (Qmax); and post-void residual volume, with volumes above 100 mL generally considered clinically meaningful. Prostate volume is measured most precisely via transrectal ultrasound (TRUS), which is considered the gold standard. A baseline assessment before starting either treatment should cover IPSS, Qmax, prostate volume, and a PSA test. Your PSA test results matter especially here, since finasteride lowers PSA levels by roughly 50% within six months, a shift that changes how cancer screening gets interpreted. The AUA recommends finasteride mainly for men with prostate volumes above 30 to 40 mL. If you’re already on this drug or weighing it, more on finasteride monitoring in practice is worth reading. A 2026 narrative review in Translational Andrology and Urology addresses monitoring intervals in detail (tau.amegroups.org, 2026); most guidelines suggest reassessment at 3 and 12 months during the first year to evaluate symptom response and rule out progression.Baseline assessment before starting treatment
Before you start either option, your doctor should document IPSS score, Qmax, post-void residual, prostate volume (via TRUS when feasible), and a PSA. Saw palmetto doesn’t require the same monitoring for PSA interpretation, but it’s worth establishing a baseline regardless, since some men on saw palmetto transition to finasteride later if symptoms worsen.What the Research Actually Shows
One thing often left out of these comparisons: placebo response rates in BPH trials run unusually high, sometimes 30 to 40%. Any treatment showing “improvement” in a small trial without a placebo arm may just be capturing that effect. Keep that in mind when reading either set of data. For a clearer look at how saw palmetto specifically affects the prostate, the clinical picture has trade-offs worth understanding.Finasteride: the evidence
Strong human RCT and systematic review evidence supports finasteride for moderate-to-severe BPH. It produces roughly 15 to 20% improvement in IPSS scores and reduces prostate volume by about 20 to 25% over 12 months. DHT in serum drops approximately 70%, with maximal prostate volume effect seen at 6 to 12 months. A follow-up analysis of the Prostate Cancer Prevention Trial found finasteride reduced BPH risk by 40% versus placebo (HR 0.60), making it one of the strongest prevention datasets available. Evidence strength: high-quality human RCTs.Saw palmetto: what studies found
The standard clinical dose is 320 mg/day of a liposterolic extract. A 2024 multicenter RCT reported a 74.6% IPSS reduction with saw palmetto, versus 60.3% with finasteride, over six months, with no statistically meaningful between-group difference (PMC11923598). That result looks strong, but prostate volume reductions with saw palmetto are far less consistent across trials, and publication bias strongly favors positive studies. Product quality varies widely with no regulatory standardization, dosing on commercial products ranges from 54 mg to 3,600 mg, and long-term data beyond two years is largely absent. Evidence strength: moderate quality, with methodological concerns.Comparing them head-to-head
For mild symptoms, saw palmetto may perform similarly over six months. But finasteride’s advantage grows with disease severity and over time, particularly for cutting acute urinary retention risk and the need for surgery, two outcomes where saw palmetto has no convincing long-term evidence. A prospective one-year trial published in the Journal of Urology compared both agents for chronic pelvic pain syndrome and found finasteride significantly improved symptom scores (p<0.003) while saw palmetto didn’t (p=0.41) (auajournals.org). That trial hasn’t been repeated at larger scale (Ovid), but its findings remain the clearest head-to-head in that condition. You can check conventional BPH treatment options to see where each fits in the treatment ladder. A clinical comparison from Trichology Journal also notes finasteride’s more consistent DHT suppression relative to saw palmetto (trichology.com).Side Effects and Safety
Safety differences are often the deciding factor. Many men tolerate finasteride without issue, but the risks are real and worth discussing honestly.Finasteride side effects
Sexual side effects occur in roughly 4.4% of men on finasteride in clinical trials versus 2.2% on placebo, including erectile dysfunction, decreased libido, and ejaculatory changes. Most resolve after stopping the drug, but Post-Finasteride Syndrome, a cluster of persistent sexual, neurological, and psychological symptoms reported by some men after discontinuation, remains controversial. The FDA acknowledges these reports; solid prospective data on true prevalence is still limited. Analysis of 11,557 FAERS adverse event reports found psychiatric signals, including suicidality, peaked in younger men aged 18 to 40. Most men tolerate finasteride well, but this is a genuine risk to weigh, especially for younger patients. Full detail on prostate medication side effects covers the broader picture.Saw palmetto side effects
Sexual dysfunction with saw palmetto is reported far less often than with finasteride. GI complaints, nausea, diarrhea, and abdominal discomfort, are the most common issues and tend to stay mild. “Natural” doesn’t mean risk-free; a 2026 review in the International Journal of Dermatology found that only 12.8% of OTC saw palmetto products reported potential adverse effects on their labels (Wiley, 2026), a labeling gap that has real implications for safe use. Standardization is another concern: product potency varies enough that two products at the same labeled dose may not deliver equivalent amounts of active extract. If nocturia or urgency are your main complaints, read about nocturia and frequent urination and frequent urination causes, since treatment selection can differ based on your dominant symptoms.Drug interactions you should know
Finasteride has few drug interactions but can mask PSA elevation, which affects prostate cancer screening. Saw palmetto may have mild antiplatelet effects; men on blood thinners should consult their doctor before starting it. Both should be disclosed to your surgeon before any procedure involving anesthesia. According to a 2024 PubMed study, clinicians treating chronic prostatitis should factor in these interaction profiles when selecting between the two.Cost, Availability, and Practicality
Finasteride requires a prescription. Generic finasteride (5 mg) costs roughly $10 to $30 per month, making it one of the more affordable prescription options for BPH. Over five years, total drug cost is typically $600 to $1,800. Quality saw palmetto supplements run $20 to $50 per month, so costs are comparable, but without consistent standardization, you may not get equivalent potency across brands or even batches. A real-world comparative study examining finasteride and dutasteride in BPH highlights that consistent dosing matters for outcomes, something easier to guarantee with a pharmaceutical than with an unregulated supplement. Saw palmetto is available over the counter, which some men prefer, and patient satisfaction surveys show lower treatment discontinuation rates with it due to side effects. For a broader look at herbal options for enlarged prostate, several botanical approaches exist that some men incorporate alongside medical care. Quality-of-life gains reported with finasteride include reduced nighttime urination and better sleep, though men who prioritize avoiding sexual side effects often report greater satisfaction going the supplement route.Which One Should You Choose
This isn’t a decision to make from an article alone. But here’s the clinical decision framework most urologists use. Finasteride is generally the preferred choice when prostate volume exceeds 30 to 40 mL, the AUA threshold for likely benefit from 5-alpha reductase inhibitors, when acute urinary retention risk is elevated, when PSA trends suggest progressive disease, or when disease-modifying treatment is clearly needed. It’s also the evidence-supported option for chronic pelvic pain syndrome. Tracking PSA trends over time and discussing baseline values with your urologist is part of taking this path responsibly. Saw palmetto may be a reasonable starting point for men with mild to moderate IPSS scores under 19, those cautious about sexual side effects, or those who’d rather avoid a prescription while keeping an eye on symptoms. A clinical comparison covers its usefulness as part of a broader conversation about non-pharmaceutical approaches (estenove.com). Current AUA guidelines don’t recommend saw palmetto as a replacement for finasteride in men with confirmed, progressive BPH, though they do acknowledge patient preferences in shared decision-making. A systematic meta-analysis comparing BPH medications including finasteride is worth reviewing with your doctor (tau.amegroups.org). Neither option is right for everyone. The right fit depends on symptom severity, prostate size, your risk tolerance for side effects, and your doctor’s assessment.When to Talk to Your Doctor
See a doctor promptly if you notice blood in your urine, can’t urinate at all, have severe pelvic pain, or score above 19 on the IPSS. These need evaluation before any supplement is tried. And if you’ve been managing mild symptoms with lifestyle adjustments or tips to make urination easier but things are getting worse, that’s a signal to reassess. A 2025 real-world comparative study found men who delayed pharmacological treatment for progressive BPH had higher rates of acute urinary retention and surgery compared to those who started finasteride earlier. Approaches like bladder habit changes and supportive supplements can complement medical care but shouldn’t replace it when symptoms are clearly advancing. This article is informational only, it’s not a substitute for professional evaluation.Frequently Asked Questions
Does finasteride’s sexual dysfunction always resolve after stopping the drug? For most men, yes, side effects clear up within weeks to months of discontinuation. Post-Finasteride Syndrome, where symptoms persist, is real and formally acknowledged, but solid data on how often it lasts long-term is still limited. Don’t stop the drug abruptly on your own; report any such effects to your doctor and let them guide the next step. Can saw palmetto stop BPH from getting worse over time? Probably not on its own. Finasteride has strong evidence for slowing BPH progression, cutting acute urinary retention risk, and reducing the need for surgery. Saw palmetto has no equivalent long-term disease-modifying data. Is it safe to take saw palmetto and finasteride together? There’s no strong clinical evidence showing serious harm from combining them, but it’s not a well-studied combination either. The practical concern is how saw palmetto might complicate interpretation of finasteride’s PSA-lowering effect, so tell your doctor if you’re taking both, so results get read correctly.What should I do if I’m already taking finasteride but want to try saw palmetto instead?
Don’t stop finasteride without speaking to your urologist first. Stopping a 5-alpha reductase inhibitor abruptly can allow prostate regrowth and symptom rebound. Your doctor can assess whether your prostate volume and symptom score support a transition, and whether saw palmetto alternatives or beta sitosterol options could play any adjunctive role. Alpha blockers are another class worth bringing up; read about alpha blockers for BPH as part of that conversation with your doctor.How long does it typically take to notice any changes with either treatment?
Finasteride’s urinary symptom benefits typically appear within 3 to 6 months, with maximum prostate volume reduction at 6 to 12 months. Saw palmetto studies have mostly looked at six-month windows, and individual response varies considerably depending on extract quality.Are there any foods or supplements I shouldn’t mix with finasteride or saw palmetto?
No major food interactions are documented for finasteride. Saw palmetto may mildly inhibit platelet aggregation, so pairing it with high-dose fish oil, aspirin, or warfarin warrants caution and a word with your pharmacist. A 2014 follow-up PCPT analysis (PMC4059403) notes that finasteride affects androgen metabolism broadly, so any supplement that touches hormone levels should be disclosed to your prescribing physician.Conclusion
The saw palmetto vs. finasteride question for prostate health has no single universal answer. Finasteride is the stronger, better-evidenced choice for men with moderate-to-severe BPH, larger prostate volume, or a real risk of disease progression; saw palmetto may fit better for milder symptoms or when side effects are the primary concern. Whichever path you take, bring your doctor into the decision and go in with realistic expectations. Quality matters if you’re after natural, science-backed prostate support, look for supplements built on peer-reviewed research and independently tested for purity. Explore saw palmetto vs finasteride in more depth if you want a fuller comparison before talking with your healthcare provider.This article is for informational purposes only and does not serve as medical advice. The details provided here are not a replacement for, and should never be depended upon as, professional medical advice. Always consult your physician regarding the potential risks and benefits of any treatment.
Dr. Howard Tay
MD, FACS, Board-Certified Urologist
Dr. Howard Tay, MD, FACS, is a board-certified urologist in Arizona with 25+ years of experience, recognized as a “Top Doc” by Phoenix Magazine.
Our Medical Review Process
At Ben’s Natural Health, we are committed to maintaining the highest standards of accuracy, transparency, and scientific integrity. Every piece of content is carefully developed by medical professionals and undergoes a thorough review every 12 to 24 months. This ensures that our information remains current, reliable, and rooted in credible, evidence-based research. We reference only peer-reviewed studies from reputable medical journals, providing full citations and direct links to enhance trust and confidence. Learn more about our medical review process and research standards.
Our Editorial Guidelines
For over 25 years, Ben’s Natural Health has been a trusted source of scientifically backed, reliable health information. Our editorial guidelines uphold the highest quality and integrity for every article we publish. Each piece is written by qualified experts and undergoes independent quality checks. We prioritize transparency by clearly displaying contributor credentials and biographies at the beginning of every article. Read more about our editorial standards.
Medical Disclaimer
The content on this blog is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment. While our articles are authored and reviewed by licensed medical professionals, they may not address your specific health concerns. Always consult a qualified healthcare provider before making any medical decisions.
Article Sources
- https://www.preprints.org/manuscript/202509.2277/v1/download
- Mederos RG, Bello MR, Travieso JCF, Gastón MP, Feijoo SC, Rech MH, et al. (2025). Comparative Study of the Efficacy and Tolerability of Palmex® (Roystonea regia Lipid Extract), Saw Palmetto, Finasteride and Tamsulosin in Patients with Benign Prostatic Hyperplasia. Urology research & practice, 50(5), 302-309. https://doi.org/10.5152/tud.2025.24067
- Mustafa Farooqi, Paige Bird, Samuel Lassiter, & Florian A. Stroie (2026). Low-dose finasteride in benign prostatic hyperplasia: a comprehensive narrative review of efficacy, safety, and preventative potential. Translational Andrology and Urology, 15(3), 90-90. https://doi.org/10.21037/tau-2025-aw-841
- Parsons JK, Schenk JM, Arnold KB, Messer K, Till C, Thompson IM, et al. (2012). Finasteride reduces the risk of incident clinical benign prostatic hyperplasia. European urology, 62(2), 234-41. https://doi.org/10.1016/j.eururo.2012.03.007
- https://www.auajournals.org/doi/10.1097/01.ju.0000101487.83730.80
- A Prospective, 1-Year Trial Using Saw Palmetto… : Journal of Urology. Ovid. https://www.ovid.com/jnls/auajuro/abstract/10.1097/01.ju.0000101487.83730.80~a-prospective-1-year-trial-using-saw-palmetto-versus?redirectionsource=fulltextview
- Review: Finasteride vs. Saw Palmetto in DHT Inhibition and Hair Loss Treatment. Trichology.com. https://trichology.com/trichologyjournal/finasteride-vs-saw-palmetto/
- Yu A, Bai Z, Wang Y, Luo Z, Du X, Chen M, et al. (2025). Impact of finasteride on modulating the risk and clinical outcomes of bladder cancer: insights from a comprehensive meta-analysis. Frontiers in pharmacology, 16, 1471442. https://doi.org/10.3389/fphar.2025.1471442
- https://onlinelibrary.wiley.com/doi/10.1111/ijd.17987
- Steven A Kaplan, Michael A Volpe, & Alexis E Te (2004). A prospective, 1-year trial using saw palmetto versus finasteride in the treatment of category III prostatitis/chronic pelvic pain syndrome. The Journal of urology, 171(1), 284-288. https://doi.org/10.1097/01.ju.0000101487.83730.80
- Yang, Dae Yul, Seo, Won-Woo, Park, Rae Woong, Rhee, Sang Youl, Cha, Jae Myung, Hah, Yoon Soo, et al. (2025). Comparison of Finasteride and Dutasteride on Risk of Prostate Cancer in Patients with Benign Prostatic Hyperplasia: A Pooled Analysis of 15 Real-world Databases. The World Journal of Men, 43(1), 188-196. https://doi.org/10.5534/wjmh.230327
- Can Saw Palmetto Replace Finasteride? A Clinical Comparison. Estenove. https://www.estenove.com/blog/can-saw-palmetto-really-replace-finasteride/
- Yao Li, Jie Ma, Xin-Hua Qin, & Chuan-Yi Hu (2022). The efficacy and safety of dutasteride and finasteride in patients with benign prostatic hyperplasia: a systematic review and meta-analysis. Translational Andrology and Urology, 11(3), 31324-31324. https://doi.org/10.21037/tau-22-58
- Ratajski J, Ciechan K, Jędrzejczyk P, Kaminski TW, Uciechowski P, & Ząbkowski T (2025). Comparative Effectiveness and Safety of Finasteride and Dutasteride in the Treatment of Benign Prostatic Hyperplasia: A Real-World Retrospective Study. Medicina (Kaunas, Lithuania), 61(11). https://doi.org/10.3390/medicina61111944
Article Update History
Reviewer:
Created on September 1, 2022
Explore More
Can you overdose on Viagra? How much sildenafil is too much?
Introduction Sildenafil, also known as Viagra, is an oral medicine used to treat some medical conditions. It is used to treat erectile dysfunction and ...